methionine sulfoximine has been researched along with Arachnoidal Cerebellar Sarcoma, Circumscribed in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bigner, DD; Bullock, N; Colvin, OM; Friedman, HS; Griffith, OW; Kaufmann, SH; Ludeman, SM | 1 |
Bigner, DD; Colvin, OM; Elion, GB; Friedman, HS; Griffith, OW; Hilton, J; Lippitz, B; Schold, SC | 1 |
Bigner, DD; Colvin, OM; Elion, GB; Friedman, HS; Griffith, OW; Skapek, SX | 1 |
3 other study(ies) available for methionine sulfoximine and Arachnoidal Cerebellar Sarcoma, Circumscribed
Article | Year |
---|---|
Cyclophosphamide resistance in medulloblastoma.
Topics: Aldehyde Dehydrogenase; Buthionine Sulfoximine; Cerebellar Neoplasms; Child; Child, Preschool; Cyclophosphamide; Drug Resistance; gamma-Glutamyltransferase; Glutathione; Glutathione Transferase; Humans; Infant; Male; Medulloblastoma; Methionine Sulfoximine; Sensitivity and Specificity; Tumor Cells, Cultured | 1992 |
Increased melphalan activity in intracranial human medulloblastoma and glioma xenografts following buthionine sulfoximine-mediated glutathione depletion.
Topics: Animals; Brain Neoplasms; Buthionine Sulfoximine; Drug Interactions; Female; Glioma; Glutathione; Humans; Male; Medulloblastoma; Melphalan; Methionine Sulfoximine; Mice; Mice, Nude; Neoplasm Transplantation | 1989 |
Enhanced melphalan cytotoxicity following buthionine sulfoximine-mediated glutathione depletion in a human medulloblastoma xenograft in athymic mice.
Topics: Animals; Buthionine Sulfoximine; Female; Glutathione; Humans; Male; Medulloblastoma; Melphalan; Methionine Sulfoximine; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Transplantation, Heterologous; Tumor Cells, Cultured | 1988 |